Parkinsonism associated with Sjogren's syndrome: Three cases and a review of the literature

Movement Disorders

Volumn 14, Issue 2, 1999, Pages 262-268

  Walker, Ruth H ^a   Spiera, Harry ^a   Brin, Mitchell F ^a   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune; Parkinsonism; Sjogren's syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; PARKINSONISM; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; BRAIN; METABOLISM; MIDDLE AGED; PARKINSON DISEASE; PATHOLOGY; REVIEW;

AGED; BRAIN; FEMALE; HUMANS; MIDDLE AGED; PARKINSON DISEASE, SECONDARY; SJOGREN'S SYNDROME;

EID: 0033238146     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(199903)14:2<262::AID-MDS1011>3.0.CO;2-6     Document Type: Article

References (40)

1. Hietaharju A, Jantti V, Korpela M, Frey H. Nervous system involvement in systemic lupus erythematosus. Sjogren syndrome and scleroderma. Acta Neurol Scand 1993;88:299-308.
2. Gordon RM, Silverstein A. Neurologic manifestations in progressive systemic sclerosis. Arch Neurol 1970;22:126-134.
3. Dierckx RA, Aichner F, Gerstenbrand F, Fritsch P. Progressive systemic sclerosis and nervous system involvement: a review of 14 cases. Eur Neurol 1987;26:134-140.
4. Alexander EL. Central nervous system (CNS) manifestations of primary Sjogren's syndrome: an overview. Scand J Rheumatol 1986;61(suppl):161-165.
5. Mauch E, Volk C, Kratzsch G, et al. Neurologic and neuropsychiatric dysfunction in primary Sjogren's syndrome. Acta Neurol Scand 1994;89:31-35.
6. Escudero D, Latorre P, Codina M, Coll-Canti J, Coll J. Central nervous system disease in Sjogren's syndrome. Annales de Medecine Interne (Paris) 1995;146:239-142.
7. Alexander EL. Neurologic disease in Sjogren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. Rheum Dis Clin North Am 1993;19: 869-908.
8. Moll JWB, Markusse HM, Pijnenburg JJJM, Vecht ChJ, Henzen-Logmans SC. Antineuronal antibodies in patients with neurologic complications of primary Sjogren's syndrome. Neurology 1993; 43:2574-2581.
9. Nagao T, Takagi K, Hashida H, Masaki T, Sakuta M. A case of progressive systemic sclerosis and Sjogren's syndrome complicated by parkinsonism with special reference to the beneficial effects of corticosteroids. Rinsho Shinkeigaku 1991;31:1238-1240.
10. Visser LH, Koudstaal PJ, van de Merwe JP. Hemiparkinsonism in a patient with primary Sjogren's syndrome. A case report and a review of the literature. Clin Neurol Neurosurg 1993;95:141-145.
11. Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M. Corticosteroid-responsive parkinsonism associated with primary Sjogren's syndrome. Clin Neurol Neurosurg 1994;96:327-331.
12. Creange A, Sedel F, Brugieres P, Voisin M-C, Degos JD. Primary Sjogren's syndrome presenting as progressive parkinsonian syndrome. Mov Disord 1997;12:121-123.
13. Mochizuki H, Okano M, Masaki T, Nagata N, Kamakura K. A case of Sjogren's syndrome with a high titre of antocardiolipin antibody that developed as parkinsonism. Rinsho Shinkeigaku 1997;37:57-59.
14. Walker RH, Spiera H, Brin MF, Olanow CW. Parkinsonism associated wilh Sjogren's syndrome [Abstract]. Ann Neurol 1997;42: 411.
15. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318.
16. Brooks DJ. Functional imaging in relation to parkinsonian syndromes. J Neurol Sci 1993;115:1-17.
17. Eidelberg D. Positron emission tomography studies in parkinsonism. Neurol Clin 1992;10:421-433.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ. The accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study. J Neurol Neurosurg Psychiatry 1992;55:181-184.
19. Alexander EL, Beall SS, Gordon B, et al. Magnetic resonance imaging of cerebral lesions in patients with Sjogren's syndrome. Ann Intern Med 1988;108:815-823.
20. Pierot L, Sauve C, Leger JM, et al. Asymptomatic cerebral involvement in Sjogren's syndrome: MRI findings of 15 cases. Neuroradiology 1993;35:378-380.
21. Eidelberg D, Moeller JR, Dhawan V, et al. The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 1994;14:783-801.
22. Przedborski S, Goldman S, Giladi N, et al. Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome. Adv Neurol 1993;60:501-505.
23. Gilman S, St. Laurent RT, Koeppe RA, Junck L, Kluin KJ, Lohman M. A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET [see comments]. Neurology 1995;45:1345-1352.
24. 18F]fluorodeoxyglucose and PET. Mov Disord 1998;13:268-274.
25. Eidelberg D, Moeller JR, Isikawa T, et al. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. J Nucl Med 1995;36:378-383.
26. Manthorpe R, Andersen V, Jensen OA, Oxholm P, Prause JU, Schiodt M. Editorial comments to the four sets of criteria for Sjogren's syndrome. Scand J Rheumatol 1986;61(suppl):31-35.
27. Vitali C, Bombardieri S. Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European community. Arthritis Rheum 1993;36:340-347.
28. Yamada K, Hayasaka S, Setogawa T. Test results in patients with Sjogren's syndrome defined by the Japanese criteria. Acta Ophthalmol (Copenh) 1990;68:80-86.
29. Miyawaki S, Nishiyama S. Classification criteria for Sjogren's syndrome - sensitivity and specificity of criteria of the Japanese Ministry of Health and Welfare (1977) and criteria of European community (1993). Nippon Rinsho 1995;53:2371-2375.
30. Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjogren's syndrome in Japan. Scand J Rheumatol 1986;61(suppl):26-27.
31. Drosos AA, Andonopoulos AP, Costopoulos JS, Papadimitriou CS. Moutsopoulos HM. Prevalence of primary Sjogren's syndrome in an elderly population. Br J Rheumatol 1988;27:123-127.
32. Skopouli FN, Drosos AA, Papaioannou T, Moutsopoulos HM. Preliminary diagnostic criteria for Sjogren's syndrome. Scand J Rheumatol 1986;61(suppl):22-25.
33. Manthorpe R, Oxholm P, Prause JU, Schiodt M. The Copenhagen criteria for Sjogren's syndrome. Scand J Rheumatol 1986;61 (suppl):19-21.
34. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjogren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann Rheum Dis 1994;53:637-647.
35. Fox RI, Saito I. Criteria for diagnosis of Sjogren's syndrome. Rheum Dis Clin North Am 1994;20:391-407.
36. Dong Y, Zhao Y, Guo X. Preliminary diagnostic criteria for primary Sjogren's syndrome in China. Chung Hua Nei Ko Tsa Chih 1996;35:114-117.
37. Fox RI, Robinson C, Curd J, Michelson P, Bone R, Howell FV. First international symposium on Sjogren's syndrome: suggested criteria for classification. Scand J Rheumatol 1986;61(suppl):28-30.
38. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjogren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-585.
39. Alexander E, Provost TT. Sjogren's syndrome. Association of cutaneous vasculitis with central nervous system disease. Arch Dermatol 1987;123:801-810.
40. Mellgren SI, Conn DL, Stevens JC, Dyck PJ. Peripheral neuropathy in primary Sjogren's syndrome. Neurology 1989;39:390-394.